Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (107)	5/5/2000 3:04:00 PM
From: Mike McFarland	Respond to of 2243

Just a brief thought--Since we do not see GZMO or GZTC in there, why not papa Genzyme, GENZ? I mean, if the list is going to include large cap stocks like Sepracor, I don't know why something like that should be excluded, and I'd own it before bgen, amgn or dna. As I said, just throwin' it out there, maybe GENZ is just a trading vehicle from $40 to $60 these past couple years, but it does have earnings and would probably be quite safe for the risk averse. (I own Gizzmo and Genzyme both--but would not classify myself as being averse to risk, heh)